Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$11.85 – $28.25
30% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.34B | $2.61B | $2.96B | $3.20B | $3.58B | $4.22B | $4.69B | $5.15B |
| Cost of revenue | $978.0M | $1.07B | $1.24B | $1.36B | $1.55B | $1.87B | $2.03B | $2.09B |
| Gross profit | $1.36B | $1.54B | $1.72B | $1.84B | $2.02B | $2.36B | $2.66B | $3.05B |
| Gross margin | 58.2% | 59.0% | 58.1% | 57.5% | 56.6% | 55.8% | 56.7% | 59.4% |
| R&D | $155.1M | $180.7M | $201.9M | $225.3M | $253.6M | $287.6M | $307.5M | $331.3M |
| Operating income | $541.8M | $579.3M | $809.7M | $903.7M | $1.00B | $1.13B | $1.32B | $1.69B |
| EBITDA | $680.2M | $705.8M | $990.4M | $1.10B | $1.18B | $1.36B | $1.53B | $1.91B |
| Net income | $315.6M | $404.6M | $621.7M | $474.5M | $779.4M | $897.6M | $1.02B | $1.40B |
| Net margin | 13.5% | 15.5% | 21.0% | 14.8% | 21.8% | 21.3% | 21.8% | 27.2% |
| EPS (diluted) | 2.19 | 2.80 | 4.27 | 3.24 | 5.30 | 6.09 | 6.92 | 9.51 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $6.1B | $1.22 | $1.21–$1.26 | 1 |
| 2028 | $6.5B | $1.34 | $1.33–$1.38 | 1 |
| 2029 | $7.0B | $1.45 | $1.44–$1.49 | 1 |
| 2030 | $7.7B | $1.61 | $1.60–$1.66 | 1 |
Forward consensus · source: Financial Modeling Prep
RESMED INC ORD
No one on the platform currently holds RSMDF.
No tracked institution reports a position in RSMDF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2010-08-12 | 2-for-1 |
No one on the platform has traded RSMDF yet.
| $30.6B |
| — |
| HLNCFHaleon plc | $4.60 | -1.39% | $40.6B | — |
| HOCPFHOYA Corporation | $168.50 | -2.80% | $56.4B | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
Trading at 1.9× earnings vs its 3.0× historical median P/E.
Fair value ≈ $26.86 · price $16.72 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.